About Us

Sterin Labs Private Limited

Our Mission

crisis_alert

We dedicate our resources to the conversion of the best drug delivery and dosage form into a commercially viable drug product. We dedicate our spirit of true partnership with all our customers to develop together.

Our Approach

handshake
  • We have a broad toolbox of technologies and in-depth scientific expertise that we utilise to add value to your challenging and ambitious projects.
  • We believe that each project is unique and deserves the right formulation and dosage form to serve our customers as well as the patients.
  • We are committed to the highest ethical and scientific standards guided by patient safety and data-driven science.
  • We innovate by our experience and capability to advance technology by applying multidisciplinary expertise and science to new research questions.
  • We value our customers and strive to build long-term, trusted relationships by delivering our promise on the projects rapidly and with high flexibility to customers’ specific needs.

We believe that any innovation starts with a challenge or unusual idea, however each challenge or idea is worth-while to be explored.

Sterin Labs Private Limited

Experienced Leadership

BOARD OF DIRECTORS

CEO FOUNDER

Srinivas Reddy

Founder and CEO.

Srinivas is an expert in Information Technology and has strong 17 + years of experience in Full Life Cycle Management. He is a dynamic, second-generation entrepreneur, adept at spotting unique value propositions and high-potential business opportunities. He brings substantial experience to Sterin Labs in areas of HR, finance, Informationtechnology, and business strategy.
CSO in Pharma

Kamalanathan Srinivasan

Founder and CSO

17+ years, with experience in NCE, NDDS, and generic formulation development. Kamalanathan is a noted inventor with multiple patents in the area of pharmaceutical formulation development. He is an expert in formulating development strategies for Parenteral dosage forms and selecting suitable dosage forms for FIH and subsequent clinical studies. Throughout his career, he has led a team of formulation, portfolio management, and business development to support pre-formulation, formulation development, scale-up, process characterization and technology transfer for multiple ANDA, NDAs, INDs for top global pharmaceutical organizations for regulated and semi-regulated markets. He has provided technical leadership for the successful development of multiple complex generics for NCEs (at various phases of development) and 505(b)(2)s.
Founder and COO

Ravindhra Reddy

Founder and COO

18+ of analytical experience in NCE, NDDS, and generic formulation development. Ravindhra is an expert in analytical development and validation of analytical methods, troubleshooting, planning, and execution of all the projects within timelines on priority in accordance with GLP. Experienced in setting up an analytical lab, dealing with vendors, procurement, maintenance, compliance, and validation of instruments, Throughout his career, he has led a department of analytical, portfolio management, and business development to support pre-formulation, formulation development, and technology transfer for multiple products for top global pharmaceutical organizations for regulated and semi-regulated markets. He has provided technical leadership for the successful development of complex analytical methods for multiple dosage forms and method transfer.
expand_less